Search
Search Results
##search.searchResults.foundPlural##
-
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1333PDF: 927HTML: 333 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5285PDF: 1366HTML: 2863Cover letter: 216 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1878PDF: 841HTML: 10346Figures 1,2,3: 206 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2523PDF: 1283HTML: 3614Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 430 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2190PDF: 1591HTML: 650 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4539PDF: 1513HTML: 8530 -
-
SOLITARY PLASMACYTOMA
4038PDF: 2232HTML: 1360fIGURES 1,2: 243 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4262PDF: 1999HTML: 1946 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1512PDF: 1047HTML: 129 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1424PDF: 940HTML: 421 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
2144PDF: 857HTML: 360 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8193PDF: 4374HTML: 7544 -
SICKLE CELL ANAEMIA AND MALARIA
11690PDF: 7230HTML: 24013Figures Malaria and SCK: 236 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2704PDF: 780HTML: 2320 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4051PDF: 1079HTML: 3893Untitled: 185Cneo. Fig.1: 122Untitled: 114Untitled: 142Untitled: 148 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1933HTML: 1635PDF: 1138 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2279PDF: 842HTML: 1695Figure 1: 213Table 1: 230 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
995PDF: 588Html: 276Suppl. Files: 187 -
The diagnostic pitfalls of mucormycosis
997PDF: 741HTML: 287 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS
2320PDF: 785HTML: 1296 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
158PDF: 162HTML: 11 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2450PDF: 1699HTML: 458 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2530HTML: 296PDF: 929 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1230PDF: 859HTML: 3413 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2449PDF: 1208HTML: 281 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7054PDF: 3732HTML: 812 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2095PDF: 1079HTML: 911Figure 1: 178Figure 2: 196 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2250PDF: 1789HTML: 824 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1626PDF: 869HTML: 1078Picture 1: 187 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1361PDF: 982HTML: 496 -







